FRZB Up-regulation is Correlated with Hepatic Metastasis and Poor Prognosis in Colon Carcinoma Patients with Hepatic Metastasis

Overview

Journal Int J Clin Exp Pathol

Specialty Pathology

Date 2015 Jun 23

PMID 26097596

Citations 4

Authors

Yanping Shen

Fang Zhang

Huanrong Lan

Ke Chen

Qi Zhang

Guoming Xie

Lisong Teng

Ketao Jin

Affiliations

Soon will be listed here.

Abstract

Frizzled-related protein (FRZB) was up-regulated in hepatic metastasis samples compared with primary colon cancer samples in our previous work. However, the clinical relevance of FRZB in colon cancer hepatic metastasis remains uncertain. The aim of this study was to assess the prognostic value of FRZB in patients with colon carcinoma hepatic metastasis after hepatic resection. FRZB expression was evaluated by immunohistochemistry in formalin-fixed paraffin embedded (FFPE) primary colon carcinoma and paired hepatic metastasis tissues from 136 patients with liver metastasis from colon carcinoma that underwent hepatic resection. The relation between FRZB expression and clinicopathologic factors and long-term prognosis in these 136 patients was retrospectively examined. The prognostic significance of negative or positive FRZB expression in colon carcinoma hepatic metastasis was assessed using Kaplan-Meier survival analysis and log-rank tests. Positive expression of FRZB was correlated with liver metastasis of colon cancer. Univariate analysis indicated significantly worse overall survival (OS) for patients with a positive FRZB expression in colon carcinoma hepatic metastasis than for patients with a negative FRZB expression. Multivariate analysis showed positive-FRZB in colon carcinoma hepatic metastasis to be an independent prognostic factor for OS after hepatic resection (P = 0.001). Positive expression of FRZB was statistically significantly associated with poor prognosis of patients with colon carcinoma hepatic metastasis. FRZB could be a novel predictor for poor prognosis of patients with colon carcinoma hepatic metastasis after hepatic resection.

Citing Articles

Atypical cyclin P regulates cancer cell stemness through activation of the WNT pathway.

Sanchez-Botet A, Quandt E, Masip N, Escriba R, Novellasdemunt L, Gasa L Cell Oncol (Dordr). 2021; 44(6):1273-1286.

PMID: 34604945 PMC: 8648692. DOI: 10.1007/s13402-021-00636-7.

CircCNIH4 inhibits gastric cancer progression via regulating DKK2 and FRZB expression and Wnt/β-catenin pathway.

Shi Q, Zhou C, Xie R, Li M, Shen P, Lu Y J Biol Res (Thessalon). 2021; 28(1):19.

PMID: 34364402 PMC: 8349030. DOI: 10.1186/s40709-021-00140-x.

Single-Cell RNA Sequencing of Human Embryonic Stem Cell Differentiation Delineates Adverse Effects of Nicotine on Embryonic Development.

Guo H, Tian L, Zhang J, Kitani T, Paik D, Lee W Stem Cell Reports. 2019; 12(4):772-786.

PMID: 30827876 PMC: 6449785. DOI: 10.1016/j.stemcr.2019.01.022.

Immunohistochemical investigation of prognostic biomarkers in resected colorectal liver metastases: a systematic review and meta-analysis.

Toren W, Ansari D, Andersson R Cancer Cell Int. 2019; 18:217.

PMID: 30602942 PMC: 6307223. DOI: 10.1186/s12935-018-0715-8.

References

Kopetz S, Chang G, Overman M, Eng C, Sargent D, Larson D . Improved survival in metastatic colorectal cancer is associated with adoption of hepatic resection and improved chemotherapy. J Clin Oncol. 2009; 27(22):3677-83. PMC: 2720081. DOI: 10.1200/JCO.2008.20.5278. View

Hebbar M, Pruvot F, Romano O, Triboulet J, De Gramont A . Integration of neoadjuvant and adjuvant chemotherapy in patients with resectable liver metastases from colorectal cancer. Cancer Treat Rev. 2009; 35(8):668-75. DOI: 10.1016/j.ctrv.2009.08.005. View

Qin S, Zhang Z, Li J, Zang L . FRZB knockdown upregulates β-catenin activity and enhances cell aggressiveness in gastric cancer. Oncol Rep. 2014; 31(5):2351-7. DOI: 10.3892/or.2014.3109. View

Adam R, Aloia T, Levi F, Wicherts D, de Haas R, Paule B . Hepatic resection after rescue cetuximab treatment for colorectal liver metastases previously refractory to conventional systemic therapy. J Clin Oncol. 2007; 25(29):4593-602. DOI: 10.1200/JCO.2007.10.8126. View

Nordlinger B, Sorbye H, Glimelius B, Poston G, Schlag P, Rougier P . Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial. Lancet. 2008; 371(9617):1007-16. PMC: 2277487. DOI: 10.1016/S0140-6736(08)60455-9. View

Wang S, Krinks M, Lin K, Luyten F, Moos Jr M . Frzb, a secreted protein expressed in the Spemann organizer, binds and inhibits Wnt-8. Cell. 1997; 88(6):757-66. DOI: 10.1016/s0092-8674(00)81922-4. View

Ekstrom E, Sherwood V, Andersson T . Methylation and loss of Secreted Frizzled-Related Protein 3 enhances melanoma cell migration and invasion. PLoS One. 2011; 6(4):e18674. PMC: 3072980. DOI: 10.1371/journal.pone.0018674. View

Hirata H, Hinoda Y, Ueno K, Majid S, Saini S, Dahiya R . Role of secreted frizzled-related protein 3 in human renal cell carcinoma. Cancer Res. 2010; 70(5):1896-905. DOI: 10.1158/0008-5472.CAN-09-3549. View

Leyns L, Bouwmeester T, Kim S, Piccolo S, De Robertis E . Frzb-1 is a secreted antagonist of Wnt signaling expressed in the Spemann organizer. Cell. 1997; 88(6):747-56. PMC: 3061830. DOI: 10.1016/s0092-8674(00)81921-2. View

10.

Banyai L, Patthy L . The NTR module: domains of netrins, secreted frizzled related proteins, and type I procollagen C-proteinase enhancer protein are homologous with tissue inhibitors of metalloproteases. Protein Sci. 1999; 8(8):1636-42. PMC: 2144412. DOI: 10.1110/ps.8.8.1636. View

11.

Lan H, Jin K, Xie B, Han N, Cui B, Cao F . Heterogeneity between primary colon carcinoma and paired lymphatic and hepatic metastases. Mol Med Rep. 2012; 6(5):1057-68. DOI: 10.3892/mmr.2012.1051. View

12.

Mandal D, Srivastava A, Mahlum E, Desai D, Maran A, Yaszemski M . Severe suppression of Frzb/sFRP3 transcription in osteogenic sarcoma. Gene. 2006; 386(1-2):131-8. DOI: 10.1016/j.gene.2006.08.030. View

13.

McMillan D, McArdle C . Epidemiology of colorectal liver metastases. Surg Oncol. 2007; 16(1):3-5. DOI: 10.1016/j.suronc.2007.04.008. View

14.

Hoang B, Moos Jr M, Vukicevic S, Luyten F . Primary structure and tissue distribution of FRZB, a novel protein related to Drosophila frizzled, suggest a role in skeletal morphogenesis. J Biol Chem. 1996; 271(42):26131-7. DOI: 10.1074/jbc.271.42.26131. View

15.

Killock D . Osteoarthritis: Frzb knockout reveals the complexity of Wnt signaling in joint homeostasis. Nat Rev Rheumatol. 2012; 8(3):123. DOI: 10.1038/nrrheum.2012.15. View

16.

Kristensen I, Haaber J, Lyng M, Knudsen L, Rasmussen T, Ditzel H . Myeloma plasma cell expression of osteoblast regulatory genes: overexpression of SFRP3 correlates with clinical bone involvement at diagnosis. Leuk Lymphoma. 2012; 54(2):425-7. DOI: 10.3109/10428194.2012.708027. View

17.

Qu Y, Li J, Cai Q, Wang Y, Gu Q, Zhu Z . Over-expression of FRZB in gastric cancer cell suppresses proliferation and induces differentiation. J Cancer Res Clin Oncol. 2007; 134(3):353-64. DOI: 10.1007/s00432-007-0291-0. View

18.

Masi G, Loupakis F, Pollina L, Vasile E, Cupini S, Ricci S . Long-term outcome of initially unresectable metastatic colorectal cancer patients treated with 5-fluorouracil/leucovorin, oxaliplatin, and irinotecan (FOLFOXIRI) followed by radical surgery of metastases. Ann Surg. 2009; 249(3):420-5. DOI: 10.1097/SLA.0b013e31819a0486. View

19.

Jemal A, Bray F, Center M, Ferlay J, Ward E, Forman D . Global cancer statistics. CA Cancer J Clin. 2011; 61(2):69-90. DOI: 10.3322/caac.20107. View

20.

Guo Y, Xie J, Rubin E, Tang Y, Lin F, Zi X . Frzb, a secreted Wnt antagonist, decreases growth and invasiveness of fibrosarcoma cells associated with inhibition of Met signaling. Cancer Res. 2008; 68(9):3350-60. PMC: 2824245. DOI: 10.1158/0008-5472.CAN-07-3220. View